Production (Stage)
Black Diamond Therapeutics, Inc.
BDTX
$1.99
-$0.06-2.93%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 56.54M | -15.99M | -15.56M | -19.91M | -18.23M |
| Total Depreciation and Amortization | 87.00K | 85.00K | 86.00K | 86.00K | 86.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.04M | 1.66M | 1.67M | 4.88M | 1.51M |
| Change in Net Operating Assets | -5.26M | -816.00K | 2.48M | 217.00K | -4.57M |
| Cash from Operations | 53.41M | -15.06M | -11.32M | -14.73M | -21.20M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 13.00K | 8.00K | 48.00K | 38.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 8.53M | 27.76M | 2.15M | 702.00K | -13.73M |
| Cash from Investing | 8.55M | 27.77M | 2.19M | 740.00K | -13.73M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 32.00K | 291.00K | -- | 21.38M | 4.13M |
| Repurchase of Common Stock | -- | -- | -252.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 32.00K | 291.00K | -252.00K | 21.38M | 4.13M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 61.99M | 13.01M | -9.38M | 7.39M | -30.80M |